Community optometrists able to diagnose glaucoma accurately

Article

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment.

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment, according to a report published online ahead of print by the British Journal of Ophthalmology.

Augusto Azuara Blanco and colleagues from the Aberdeen Royal Infirmary and the University of Aberdeen, UK compared the diagnostic abilities of accredited glaucoma optometrists (AGO) with that of routine hospital eyecare against a reference standard of expert opinion, i.e. consultant ophthalmologists with a special interest in glaucoma.

A total of 100 subjects were examined. People suspected of having glaucoma underwent full assessment both in the newly established, optometry led glaucoma management scheme and in a consultant led hospital eye service.

Agreement between the AGO and consultant ophthalmologists was significant at 89%. Agreement regarding the need for treatment was also substantial (88%) whilst the agreement between trainee ophthalmologist and consultant ophthalmologist was moderate (83%).

It was concluded that community optometrists trained in glaucoma are able to offer satisfactory diagnoses and initiation of treatment.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.